Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis
Clinical trial NCT07169682 · COMPLETED
Trial details
- NCT number
- NCT07169682
- Sponsor
- National and Kapodistrian University of Athens
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-01
- Primary completion
- 2024-09-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.